Home
>
National Drug Code (NDC)
>
Etodolac
Etodolac - 51672-4017-1 - (Etodolac)
Drug Information of Etodolac
| Product NDC: | 51672-4017 |
| Proprietary Name: | Etodolac |
| Non Proprietary Name: | Etodolac |
| Active Ingredient(s): | 300 mg/1 & nbsp; Etodolac |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Etodolac
| Product NDC: | 51672-4017 |
| Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075078 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19980430 |
Package Information of Etodolac
| Package NDC: | 51672-4017-1 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (51672-4017-1) |
NDC Information of Etodolac
| NDC Code | 51672-4017-1 |
| Proprietary Name | Etodolac |
| Package Description | 100 CAPSULE in 1 BOTTLE (51672-4017-1) |
| Product NDC | 51672-4017 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Etodolac |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19980430 |
| Marketing Category Name | ANDA |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Substance Name | ETODOLAC |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
